Opiod Producer Seeks Indemnity from CGL Insurers

Post number 5288

Read the full article at https://lnkd.in/guNhStN2, see the full video at https://lnkd.in/gYqkk-n3 and at https://lnkd.in/g8U3ehuc, and at https://zalma.com/blog plus more than 5250 posts.

Insurers Exclude Damages Due to Insured’s Products

In Matthew Dundon, As The Trustee Of The Endo General Unsecured Creditors’ Trust v. ACE Property And Casualty Insurance Company, et al., Civil Action No. 24-4221, United States District Court, E.D. Pennsylvania (February 10, 2026) Matthew Dundon, trustee of the Endo General Unsecured Creditors’ Trust, sued multiple commercial general liability (CGL) insurers for coverage of opioid-related litigation involving Endo International PLC a pharmaceutical manufacturer.

KEY FACTS

Beginning as early as 2014, thousands of opioid suits were filed by governments, third parties, and individuals alleging harms tied to opioid manufacturing and marketing.

Bankruptcy & Settlements

Endo filed Chapter 11 in August 2022; before bankruptcy it allegedly settled many opioid suits and incurred substantial defense costs. A reorganization plan confirmed in March 2024 discharged opioid claims and created the Trust with Dundon as trustee.

Motions

CGL insurers sought summary judgment on late notice and the Products Exclusion; the Trustee cross-moved.
Governing Law – Pennsylvania Insurance Law.

Insurance Policies are construed under traditional contract principles; unambiguous language enforced as written. Coverage interpretation is a question of law when unambiguous.

DISCUSSION & HOLDINGS

Endo failed to provide notice “as soon as practicable,” notifying insurers only when the coverage action was filed in 2024 — after settlements and bankruptcy resolution.

Prejudice Not Established as a Matter of Law.

Although late notice impaired insurers’ procedural rights (investigation, defense participation), Third Circuit precedent requires proof that lateness probably altered the substantive outcome (e.g., lower settlement or viable defenses lost). The record showed factual disputes on that point. Result: Summary judgment denied on late notice.
Unbranded Promotions Included.

Allegations show Endo’s unbranded marketing was part of efforts to expand opioid use and sales; injuries allegedly flowing from such campaigns bear a sufficient causal connection to Endo’s products. The Products Exclusion bars coverage for bodily injury claims arising from Endo’s products, including unbranded promotions.

ANALYSIS

The Court enforced clear notice terms but adhered to Pennsylvania’s insurer‑protective yet insured‑fair actual prejudice requirement, refusing to presume prejudice solely from post‑settlement notice absent proof of a different likely outcome.

BOTTOM LINE

Late Notice:

Breach established, but no summary judgment due to disputed actual prejudice.

Products Exclusion:

Coverage barred for bodily injury claims arising from Endo’s products, including unbranded promotions.

Endo Breached the Notice Provisions by Providing Late Notice

The CGL Insurers’ policies contained clear and unambiguous provisions requiring that notice be provided to them “as soon as practicable of an ‘occurrence’ or an offense which may result in a claim.”

A Genuine Dispute Remains as to Whether the CGL Insurers Suffered Actual Prejudice

The CGL Insurers argued in their motion for summary judgment that “post-settlement notice is prejudicial” to insurers as a matter of law. The Court found that there is a genuine dispute of material fact as to whether this procedural handicap created by the late notice has led to disadvantageous, substantive results for the CGL Insurers.

Summary Judgment Was Granted in Favor of the CGL Insurers on the Basis of the Products Exclusion

The Court held that the Products Exclusion bars coverage of the Opioid Suits to the extent the underlying suits involve claims for bodily injury arising from Endo’s products, including Endo’s unbranded promotions.

The Court also granted in part and denied in part the CGL Insurers’ Motion for Partial Summary Judgment. Finally, the Court denied the Trustee’s Cross-Motion for Partial Summary Judgment.

ZALMA OPINION

The USDC issued a lengthy opinion concluding the even though the notice of the losses was later than was proper the insurers failed to prove that the late notice caused them damage but the insurers were able to prove that the exclusions applied. Lawsuits from major tort situations like the opioid catastrophe are usually not intended to cover such losses and the exclusions were clear and unambiguous. Resolving this type of coverage dispute is not easy and it took the USDC more than 50 pages to explain the decisions and, yet, all the issues were not resolved.

(c) 2026 Barry Zalma & ClaimSchool, Inc.

Please tell your friends and colleagues about this blog and the videos and let them subscribe to the blog and the videos.

Subscribe to my substack at https://barryzalma.substack.com/subscribe

Go to X @bzalma; Go to Barry Zalma videos at Rumble.com at https://rumble.com/account/content?type=all; Go to Barry Zalma on YouTube- https://www.youtube.com/channel/UCysiZklEtxZsSF9DfC0Expg; Go to the InsuranceClaims Library – https://lnkd.in/gwEYk.